PFE eyes Q2 earnings beat as strength in Vyndaqel and Padcev is expected to offset declines from Eliquis, Ibrance and Prevnar ...

Report found business relationships between telehealth and pharma companies may indirectly lead patients toward certain ...

PFE's non-oncology portfolio draws focus in Q2, with strength in Vyndaqel and Nurtec offsetting some vaccine softness.

One relatively safe bet about how Pfizer's lineup will look different five years from now is that the company will be a ...

Bristol Myers and Pfizer will sell Eliquis directly to U.S. patients at a discounted rate with transparent pricing and nationwide delivery.

Pfizer, Inc. (NYSE:PFE) is one of the high-margin pharma stocks to buy now. Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer, Inc.

A direct-to-consumer program for its drugs could bring down higher U.S. drug prices while cutting out pharmacy benefit ...

Roche (OTCQX:RHHBY) (OTCQX:RHHBF) announced Thursday it has begun discussions with the U.S. government to launch ...

Pfizer (PFE), in collaboration with Bristol Myers Squibb, has introduced a direct-to-patient option for Eliquis®, potentially enhancing patient access and affordability. Over the past quarter, ...

Pfizer, Inc. (NYSE: PFE) is one of the high-margin pharma stocks to buy now. Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer, Inc. (NYSE:PFE) have announced a direct-to-patient program for Eliquis ...

Bristol Myers Squibb and Pfizer will begin offering their top-selling heart medicine Eliquis through a new online service at a discounted price — the latest example of pharmaceutical companies ...

This release contains forward-looking information about the Bristol Myers Squibb-Pfizer Alliance launch of a new direct-to-patient option for purchasing Eliquis via the Alliance’s patient ...